#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Angiosarcoma non-metastatic Albright's disease Immune-mediated myositis Pancreatic neuroendocrine tumour Peritoneal neoplasm Myxofibrosarcoma Thrombotic thrombocytopenic purpura Optic glioma Palmar-plantar erythrodysaesthesia syndrome Still's disease Microscopic polyangiitis Non-Hodgkin's lymphoma Astrocytoma Hypocalcaemia Multifocal motor neuropathy More trials…

    Learn about Rare Diseases

    Loeys-Dietz syndrome – Treatment Langerhans’ cell histiocytosis Hepatoblastoma – Basic Information Systemic sclerosis pulmonary – Basic Information Familial amyotrophic lateral sclerosis – Basic Information Focal segmental glomerulosclerosis – Basic Information Epidermolysis bullosa Cystic fibrosis – Trials in Disease Glomerulonephritis rapidly progressive – Diagnostics Mantle cell lymphoma stage III – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Paroxetine JNJ-75276617 Tropicamide Lisaftoclax Rocatinlimab Esketamine Hydrochloride Varnimcabtagene Autoleucel PARECOXIB PUCOTENLIMAB Lasmiditan Dexpanthenol YOHIMBINE HYDROCHLORIDE Cinnarizine Emraclidine Loperamide Hydrochloride Disulfiram Sasanlimab ZIGAKIBART Tinzaparin Sodium Ck-0045 More therapies…

    Learn about Your Condition

    Generalised anxiety disorder Complex regional pain syndrome Ventricular fibrillation Neuroblastoma Hypersomnia Neurodegenerative disorder Rhabdoid tumour Hypercholesterolaemia Autism spectrum disorder Hypoxia Major depression Macular degeneration Triple negative breast cancer Erdheim-Chester disease Poor quality sleep More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nervous System Diseases

  • Montelukast Sodium for disease-modifying treatment in patients with mild‑moderate Parkinson’s disease: open‑label phase II extension study

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • Montelukast Sodium
    Sweden

  • Ticagrelor versus placebo to prevent cerebral ischemia in patients with low‑grade aneurysmal subarachnoid hemorrhage

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Subarachnoid haemorrhage
    Investigated Drugs:
    • Ticagrelor
    France

  • Safety, CNS penetration and target engagement of Mirivadelgat in participants with Parkinson’s disease

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Parkinson’s disease
    Norway

  • Randomized Study of Tolebrutinib Versus Rituximab in Adults with Multiple Sclerosis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Relapsing multiple sclerosis
    • Multiple sclerosis
    Investigated Drugs:
    • Tolebrutinib
    • Rituximab
    Sweden

  • Long‑Term Safety and Tolerability of KarXT in Adolescents with Schizophrenia and of KarXT + KarX‑EC in Children and Adolescents with Autism‑Related Irritability

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Autism spectrum disorder
    • Schizophrenia
    Investigated Drugs:
    • Trospium Chloride
    • Xanomeline Tartrate
    Romania

  • Iodixanol in Cerebral Angiography for Patients with Unruptured Intracranial Aneurysms

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Intracranial aneurysm
    Investigated Drugs:
    • Iodixanol
    France
Previous Page
1 … 61 62 63 64 65 … 141
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!